TESERPATUREV

UNII:	6S57D3Y2F5
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	TESERPATUREV
GSRS Full Record:	6S57D3Y2F5 i

1802360-34-4
A conditionally-replicating oncolytic Herpes simplex virus type 1 (HSV-1) strain F that has genetically engineered deletions within both copies of the γ34.5 gene and within the α47 gene, and further modified by insertion of an expressible beta-galactosidase (LacZ) gene in the ICP6 locus
AN ONCOLYTIC HERPES SIMPLEX VIRUS-1 VECTOR CONTAINING MUTATIONS .GAMMA.34.5, ICP6 AND .ALPHA.47 WITH SELECTIVE TOXICITY TO TUMOR CELLS
G-47.DELTA.
TESERPATUREV [WHO-DD]
teserpaturev [INN]

Common Chemistry
i
Inxight Drugs
i
NCI Thesaurus
i

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

TESERPATUREV

Synonyms and Mappings

Resources